PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20637838-8	2010	Sorafenib inhibited the activation of the MAP kinase p38 and its downstream target mitogen and stress activated protein kinase (MSK), and partially inhibited protein kinase B (AKT) and its subsequent inactivation of the downstream target glycogen synthase kinase 3-beta (GSK3-beta).	Sorafenib	0-9	glycogen synthase kinase 3 beta	Mus musculus	238-269	
20637838-8	2010	Sorafenib inhibited the activation of the MAP kinase p38 and its downstream target mitogen and stress activated protein kinase (MSK), and partially inhibited protein kinase B (AKT) and its subsequent inactivation of the downstream target glycogen synthase kinase 3-beta (GSK3-beta).	Sorafenib	0-9	glycogen synthase kinase 3 beta	Mus musculus	271-280